Developing New Ligand Platforms for MRI Contrast Agents

A series of lanthanide complexes, {[CpCo(P=O(OR)2)3]2Ln(H2O)x}+Cl- (Ln = Nd, Eu, Tb, Yb; R = Et, Ph), (Kläui)2Ln, were prepared. The related complex {[CpCo(P=O(OPh)2)3]2Yb}+ [CoCl3(THF)]- was crystallographically characterized and the cation in this case was confirmed to be 6-coordinate and solvent...

Full description

Bibliographic Details
Main Author: Allen, Kevin John Harvey
Other Authors: Berg, David Jay
Language:English
en
Published: 2014
Subjects:
MRI
Online Access:http://hdl.handle.net/1828/5448
id ndltd-uvic.ca-oai-dspace.library.uvic.ca-1828-5448
record_format oai_dc
spelling ndltd-uvic.ca-oai-dspace.library.uvic.ca-1828-54482015-01-29T16:52:37Z Developing New Ligand Platforms for MRI Contrast Agents Allen, Kevin John Harvey Berg, David Jay Hof, Fraser Alan Inorganic Chemistry MRI Synthesis Klaui Calix[4]arene Oxazoline A series of lanthanide complexes, {[CpCo(P=O(OR)2)3]2Ln(H2O)x}+Cl- (Ln = Nd, Eu, Tb, Yb; R = Et, Ph), (Kläui)2Ln, were prepared. The related complex {[CpCo(P=O(OPh)2)3]2Yb}+ [CoCl3(THF)]- was crystallographically characterized and the cation in this case was confirmed to be 6-coordinate and solvent free. To determine the Kläui complexes potential as magnetic resonance (MR) imaging agents, ligand exchange rates between the d0- and d60-isotopomers of the Kläui lanthanide complexes were determined in acetonitrile by electrospray mass spectrometry. The ligand exchange rate was found to increase by almost 4-orders of magnitude from the smallest (Yb) to largest ion (Nd) in acetonitrile. Additionally, the ligand exchange rate increased rapidly for the Tb complex with increasing water concentration. Changing the phosphite substituent had no significant impact on the rate of ligand exchange for R = Ph relative to R = Et. Modification to the phosphite substituents to decrease ligand exchange was unsuccessful indicating that these ligands were not suitable as MR imaging agents. Oxazoline based ligands are known to complex lanthanide ions, however, most of these complexes undergo rapid ligand exchange when not in water solution. Several novel oxazoline based ligands with increased chelation to stop ligand exchange were designed. During the course of their synthesis it was discovered that these ligands were too unstable to be used in vivo and this ligand set was abandoned for a more stable alternative. A series of ligands based on a calix[4]arene scaffold were developed. Through modifications to the upper rim of the calix[4]arene scaffold a mono, di, and tri substituted catechol calix[4]arene were designed. After the mono-catechol tri-sulfonated calix[4]arene was found to decompose in solution the catechol substituent was determined to be too reactive for use as a contrast agent. An upper rim tetra substituted iminodiacetic acid calix[4]arene was synthesized. Upon addition of the lanthanide a coordination polymer was likely forming. Using a dye displacement assay it was found that this ligand was not able to out-compete the dye for metal chelation and would not be suitable for MR use. Using established Suzuki chemistry, DO3A functionality was incorporated onto a tri-sulfonated calix[4]arene scaffold. Using a dye displacement assay it was found that the stability constant KML of this complex was similar to DO3A at pH 8.35. At pH 3.99 it was found that no displacement occurred, most likely due to intramolecular hydrogen bonding. Graduate 0488 kjallen@uvic.ca 2014-07-08T23:04:35Z 2014-07-08T23:04:35Z 2014 2014-07-08 Thesis http://hdl.handle.net/1828/5448 Tabet, S.; Douglas, S. F.; Daze, K. D.; Garnett, G. A. E.; Allen, K. J. H.; Abrioux, E. M. M.; Quon, T. T. H.; Wulff, J. E.; Hof, F., Synthetic trimethyllysine receptors that bind histone 3, trimethyllysine 27 (H3K27me3) and disrupt its interaction with the epigenetic reader protein CBX7. Bioorganic & Medicinal Chemistry 2013, 21 (22), 7004-7010. Allen, K. J. H.; Nicholls-Allison, E. C.; Johnson, K. R. D.; Nirwan, R. S.; Berg, D. J.; Wester, D.; Twamley, B., Lanthanide Complexes of the Klaui Metalloligand, CpCo(P=O(OR)2)3: An Examination of Ligand Exchange Kinetics between Isotopomers by Electrospray Mass Spectrometry. Inorganic Chemistry 2012, 51 (22), 12436-12443. English en Available to the World Wide Web http://creativecommons.org/licenses/by-nc/2.5/ca/
collection NDLTD
language English
en
sources NDLTD
topic Inorganic Chemistry
MRI
Synthesis
Klaui
Calix[4]arene
Oxazoline
spellingShingle Inorganic Chemistry
MRI
Synthesis
Klaui
Calix[4]arene
Oxazoline
Allen, Kevin John Harvey
Developing New Ligand Platforms for MRI Contrast Agents
description A series of lanthanide complexes, {[CpCo(P=O(OR)2)3]2Ln(H2O)x}+Cl- (Ln = Nd, Eu, Tb, Yb; R = Et, Ph), (Kläui)2Ln, were prepared. The related complex {[CpCo(P=O(OPh)2)3]2Yb}+ [CoCl3(THF)]- was crystallographically characterized and the cation in this case was confirmed to be 6-coordinate and solvent free. To determine the Kläui complexes potential as magnetic resonance (MR) imaging agents, ligand exchange rates between the d0- and d60-isotopomers of the Kläui lanthanide complexes were determined in acetonitrile by electrospray mass spectrometry. The ligand exchange rate was found to increase by almost 4-orders of magnitude from the smallest (Yb) to largest ion (Nd) in acetonitrile. Additionally, the ligand exchange rate increased rapidly for the Tb complex with increasing water concentration. Changing the phosphite substituent had no significant impact on the rate of ligand exchange for R = Ph relative to R = Et. Modification to the phosphite substituents to decrease ligand exchange was unsuccessful indicating that these ligands were not suitable as MR imaging agents. Oxazoline based ligands are known to complex lanthanide ions, however, most of these complexes undergo rapid ligand exchange when not in water solution. Several novel oxazoline based ligands with increased chelation to stop ligand exchange were designed. During the course of their synthesis it was discovered that these ligands were too unstable to be used in vivo and this ligand set was abandoned for a more stable alternative. A series of ligands based on a calix[4]arene scaffold were developed. Through modifications to the upper rim of the calix[4]arene scaffold a mono, di, and tri substituted catechol calix[4]arene were designed. After the mono-catechol tri-sulfonated calix[4]arene was found to decompose in solution the catechol substituent was determined to be too reactive for use as a contrast agent. An upper rim tetra substituted iminodiacetic acid calix[4]arene was synthesized. Upon addition of the lanthanide a coordination polymer was likely forming. Using a dye displacement assay it was found that this ligand was not able to out-compete the dye for metal chelation and would not be suitable for MR use. Using established Suzuki chemistry, DO3A functionality was incorporated onto a tri-sulfonated calix[4]arene scaffold. Using a dye displacement assay it was found that the stability constant KML of this complex was similar to DO3A at pH 8.35. At pH 3.99 it was found that no displacement occurred, most likely due to intramolecular hydrogen bonding. === Graduate === 0488 === kjallen@uvic.ca
author2 Berg, David Jay
author_facet Berg, David Jay
Allen, Kevin John Harvey
author Allen, Kevin John Harvey
author_sort Allen, Kevin John Harvey
title Developing New Ligand Platforms for MRI Contrast Agents
title_short Developing New Ligand Platforms for MRI Contrast Agents
title_full Developing New Ligand Platforms for MRI Contrast Agents
title_fullStr Developing New Ligand Platforms for MRI Contrast Agents
title_full_unstemmed Developing New Ligand Platforms for MRI Contrast Agents
title_sort developing new ligand platforms for mri contrast agents
publishDate 2014
url http://hdl.handle.net/1828/5448
work_keys_str_mv AT allenkevinjohnharvey developingnewligandplatformsformricontrastagents
_version_ 1716729699109961728